Overview
Thomas Regenbogen is a Hematologist practicing medicine in Ypsilanti, Michigan.
Dr. Regenbogen is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Anal Cancer, and Pleuropulmonary Blastoma.
He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 5 clinical trials.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5303 Elliott Dr Ste 210, Ypsilanti, MI 48197
1600 S Canton Center Rd, Canton, MI 48188
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
C. S. Mott Children's Hospital
Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies. Dr. Bixby is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Bixby is board certified in Hematology.
Rogel Cancer Center
Erica Campagnaro is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Campagnaro is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is board certified in Internal Medicine and Hematology.
University Of Michigan Medical Center
Rajen Mody is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Mody is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Infantile Neutropenia, Glioma, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Thomas Regenbogen
How do I make an appointment with Dr. Thomas Regenbogen?
You can book an appointment with Dr. Thomas Regenbogen by calling their office at 734-712-1000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Thomas Regenbogen a top-rated expert for Small Cell Lung Cancer (SCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Thomas Regenbogen is classified as an Distinguished expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Thomas Regenbogen specialize in?
While Dr. Thomas Regenbogen is a Hematology, they have specific expertise in Small Cell Lung Cancer (SCLC), Lung Cancer, and Anal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Thomas Regenbogen participate in research or clinical trials?
Yes. Dr. Thomas Regenbogen has published 2 articles and abstracts on conditions like Small Cell Lung Cancer (SCLC). You can view a list of Dr. Thomas Regenbogen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Thomas Regenbogen accept my insurance?
Dr. Thomas Regenbogen accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 734-712-1000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Regenbogen isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Regenbogen isDistinguished. Learn about Anal Cancer.
- EGFR Positive Lung CancerDr. Regenbogen isDistinguished. Learn about EGFR Positive Lung Cancer.
- Familial Colorectal CancerDr. Regenbogen isDistinguished. Learn about Familial Colorectal Cancer.
- Large-Cell Lung CarcinomaDr. Regenbogen isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Regenbogen isDistinguished. Learn about Lung Adenocarcinoma.
- Advanced
- Appendix CancerDr. Regenbogen isAdvanced. Learn about Appendix Cancer.
- B-Cell LymphomaDr. Regenbogen isAdvanced. Learn about B-Cell Lymphoma.
- Childhood Iron Deficiency AnemiaDr. Regenbogen isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Regenbogen isAdvanced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Chronic Myelogenous Leukemia (CML)Dr. Regenbogen isAdvanced. Learn about Chronic Myelogenous Leukemia (CML).
- Colorectal CancerDr. Regenbogen isAdvanced. Learn about Colorectal Cancer.
- Experienced
- Acute Mountain SicknessDr. Regenbogen isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with MaturationDr. Regenbogen isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without MaturationDr. Regenbogen isExperienced. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Regenbogen isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Regenbogen isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Regenbogen isExperienced. Learn about Adult Soft Tissue Sarcoma.